Skip to main content
. 2013 Feb 26;56(10):1421–1427. doi: 10.1093/cid/cit083

Table 2.

Baseline Anthropometric and Biochemical Characteristics of Participants of the European Prospective Investigation of Cancer–Norfolk Cohort Cytomegalovirus (CMV) Study (N = 12 999), Grouped by CMV Antibody Status

Negative for CMV Antibodies (n = 5366) Positive for CMV IgG Antibodies
P Valueb
Low Antibody Group (n = 2545) Middle Antibody Group (n = 2544) High Antibody Group (n = 2544) P Valuea
CMV IgG antibody, IU/mL, median (IQR) 0.2 (0.2–0.2) 3.0 (1.9–4.1) 6.9 (5.7–8.4) 14.1 (10.7–20.8) <.001 <.001
Body mass index, kg/m2, mean (SD) 26.1 (3.7) 26.4 (3.7) 26.3 (3.9) 26.5 (4.1) .45 <.001
Waist-to-hip ratio, mean (SD) 0.85 (0.1) 0.86 (0.1) 0.86 (0.1) 0.86 (0.1) .29 .02
C-reactive protein, mg/L, mean (SD) 2.9 (5.9) 3.0 (5.6) 3.3 (6.5) 3.5 (7.6) .05 .07
Ferritin, pmol/L, mean (SD) 206.5 (172) 206.4 (170) 204.6 (172) 194.1 (161) .74 .14
Fibrinogen, µmol/L, median (IQR) 8.3 (7.1–9.8) 8.5 (7.1–9.9) 8.5 (7.1–9.9) 8.8 (7.4–9.9) .18 .61
Glucose, mmol/L, median (IQR) 4.0 (3.5–4.7) 4.0 (3.5–4.7) 4.1 (3.5–4.8) 4.1 (3.6–4.8) .26 .77
Cholesterol, mmol/L, median (IQR) 6.0 (5.3–6.8) 6.1 (5.4–6.9) 6.1 (5.4–6.9) 6.1 (5.4–6.9) .07 .15
LDL, mmol/L, median (IQR) 3.8 (3.2–4.6) 3.9 (3.3–4.6) 3.8 (3.2–4.6) 3.9 (3.3–4.6) .13 .63
HDL, mmol/L, median (IQR) 1.4 (1.1–1.7) 1.4 (1.1–1.6) 1.3 (1.1–1.6) 1.4 (1.1–1.7) .001 <.001
Triglycerides, mmol/L, median (IQR) 1.5 (1.0–2.2) 1.5 (1.1–2.2) 1.6 (1.1–2.3) 1.6 (1.1–2.3) .64 <.001
Systolic blood pressure, mm Hg, mean (SD) 134.2 (17) 135.1 (18) 135.9 (18) 137.2 (19) .05 .59
Diastolic blood pressure, mm Hg, mean (SD) 82.1 (11) 82.3 (11) 82.5 (11) 82.9 (11) .09 .89

To obtain cholesterol, LDL, and HDL in mg/dL, divide mmol/L by 0.0259. To obtain triglycerides in mg/dL, divide mmol/L by 0.0113. To obtain glucose in mg/dL, divide mmol/L by 0.0555. To obtain fibrinogen in mg/dL, divide µmol/L by 0.0294. To obtain ferritin in ng/mL, divide pmol/L by 2.247.

Abbreviations: CMV, cytomegalovirus; HDL, high-density lipoprotein; IgG, immunoglobulin G; IQR, interquartile range; LDL, low-density lipoprotein; SD, standard deviation.

a Age- and sex-adjusted P value for trend among thirds of antibody within participants with positive IgG antibodies.

b Age- and sex-adjusted P value comparing participants with positive IgG antibodies to participants with negative IgG antibodies.